Clinical Studies

For additional information about Harvard Eye Associates’ clinical trials, please visit ClinicalTrials.gov.

Below is a list of ongoing studies at Harvard Eye Associates:

Cataract Surgery

Sponsor: CORD, LLC
A prospective clinical trial to evaluate the safety and effectiveness of Model SC9 Posterior Chamber Silicone Intraocular lens for primary implantation in the capsular bag of the eye for visual correction of aphakia secondary to removal of aphakia secondary to removal of a cataractous lens in adult patients with or without presbyopia.  The IOL is intended to improve near and intermediate vision as compared to a legally marketed monofocal IOL.

Principal Investigator:  John Hovanesian, MD 
Sub Investigator:  Nicoletta Stefanidis, OD

Sponsor:  Alcon Research, Ltd.
Post Approval Study of the AcrySof® IQ ReSTOR® Toric IOLs

Principal Investigator:  John Hovanesian, MD 

Sponsor: AcuFocus, Inc.
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens.

Principal Investigator:  John Hovanesian, MD 
Website: ic8lensclinicalstudy.com

Sponsor: Research InSight, LLC

An open-label, perspective survey study of patients who previously underwent cataract surgery with the Alcon Panoptix or Panoptix Toric IOL in both eyes, comparing to an existing historical dataset of patient reported outcomes with bilateral ReSTOR 3.0 implants.

Principal Investigator:  John Hovanesian, MD 

Sponsor: Research InSight, LLC

Title: The D3 Study:  Drug Delivery vs Drops–A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1% in Controlling Post-operative Pain and Inflammation in Patients Undergoing Sequential Cataract Surgery

Principal Investigator: John Hovanesian, MD

Sub Investigators: Isabell Choi, OD

 

Sponsor: Ophthalmic Consultants of Long Island

Title: CIMPLIFY: A Randomized Self Controlled Prospective Clinical Study Evaluating the Safety and Efficacy of a dropless Intracanalicular insert delivery system of DexaMethasone, Intracameral Ketorolac and Intracameral Moxifloxacin compared to traditional topical postoperative prednisolone Acetate, MoxifLoxacin and Ketorolac in controlling post-operative pain and inflammation in subjects undergoing sequential bilateral cataract surgery

Co Investigator: John Hovanesian, MD

Sub Investigator: Isabell Choi, OD

 

For additional information on our clinical studies, please contact:

Reesha Magallanes, Clinical Research Coordinator
(949) 900-5248
rmagallanes@harvardeye.com